A Difficult Decision.

The CSAG Team has had extensive and detailed deliberations about the revised offer of $3.80 that Qiagen have made for our shares. Ultimately, we have come to the decision to accept this improved offer.

With the advent of this offer, we have had to consider many factors.

CSAGs stated intention has always been to achieve a better outcome for shareholders. Whilst accepting $3.80 may not be the best outcome that we might have wished for, it is certainly a better outcome.

We are very aware of the fact that some shareholders may be disappointed with our decision. This may not be the outcome that every individual shareholder might have hoped for. However, we should all consider the fact that we are in this together. In the end, the outcome of the vote will be binding upon all of us. Accepting the offer of $3.80 is undeniably better than receiving a payment of $3.55.

It is reasonably certain that, subsequent to a rejection of the Scheme of Arrangement, the share price of Cellestis would fall somewhat and may take some substantial time before reaching a price equal to this revised offer. Whilst many of us would not be concerned with such share price movements, there are other shareholders who would be significantly disadvantaged by such an event. We could wish that this Scheme of Arrangement that creates this situation had never happened but it has.

Whatever the outcome of this Scheme of Arrangement, there is no denying that Cellestis has changed forever. It can never again be the same Company that we all originally invested in. We need to consider whether we now, under these changed circumstances, still wish to remain invested in this "new" Cellestis.

We should consider that we now all have the opportunity to exit our positions in Cellestis for immediate cash that we can invest in other ways.

For most of us, the payment of up to 7c of the payment in the form of a fully franked dividend will effectively increase the $3.80 offer by up to 3c.

We now believe that it is in our best interests to divest ourselves of our shares in Cellestis for this improved price that we have achieved, add this event to our storehouse of knowledge and move on.

We can not and should not advise individual shareholders how they should vote. However, we urge everybody to seriously, pragamatically and sensibly consider their decision.

We should also look to the positives in this story.

It is an absolute certainty that without working together to exert our strength and conviction as shareholders, we would not have achieved this improved outcome. It is a result that we should all take some pride in.

We have clearly demonstrated that our active voice should and can be heard. Together, we have taken our place at the table in this Corporate Action.

Make no mistake. If, in the end, there is credit to be assigned for this meaningful improved outcome then it belongs to all of you. Thank You.